Neovascular Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Neovascular Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 clinical trial results evaluating the efficacy and safety of ONS-5010 in subjects with neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders [Phase 3]
Phase 3 trial assessing the safety of ONS-5010 in subjects with visual impairment due to retinal disorders completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial results for ONS-5010 in neovascular age-related macular degeneration completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Update: Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD [Phase 2, Phase 3]
Pivotal Phase 2/3 study of ABBV-RGX-314 (RGX-314) gene therapy for neovascular age-related macular degeneration evaluates subretinal deliver…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD [Phase 3]
Phase 3 trial update evaluating 36-week refill exchanges of Port Delivery System with ranibizumab in neovascular age-related macular degener…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Extension Study for the Port Delivery System With Ranibizumab (Portal) [Phase 3]
A Phase 3 extension study for the Port Delivery System with ranibizumab in neovascular age-related macular degeneration is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial results for SYL1801 in patients with neovascular age-related macular degeneration have been completed, focusing on dose-findin…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Extension Study for the Port Delivery System With Ranibizumab (Portal) [Phase 3]
Extension study for the Port Delivery System delivering ranibizumab for neovascular age-related macular degeneration is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
This clinical trial update evaluates the durability of three monthly loading doses of Faricimab in treatment-naïve Neovascular age-related m…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration [Phase 3]
Phase 3 clinical trial comparing QL1207H Injection to aflibercept for neovascular age-related macular degeneration is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 [Phase 1]
A Phase 1b study evaluating safety, tolerability, pharmacokinetics, and exploratory efficacy of intravitreal OLN324 in diabetic macular edem…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS) [Phase 2]
Phase 2 VENUS study evaluating the safety and efficacy of LX102 gene therapy for neovascular age-related macular degeneration; the trial is …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)
This clinical trial update notes the completion of a study evaluating the conjunctiva and Tenon's capsule status in healthy subjects and in …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration
This clinical trial update describes evaluating switching from 2 mg aflibercept to 8 mg aflibercept in patients with neovascular age-related…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
This entry provides an update on the OPTIC-EXT long-term extension study of ADVM-022 for wet age-related macular degeneration. The trial is …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome) [Phase 3]
Phase 3 Velodrome trial update for the Port Delivery System delivering ranibizumab in neovascular age-related macular degeneration; the stud…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD [Phase 3]
Phase 3 trial comparing LUBT010, a proposed ranibizumab biosimilar, with Lucentis for neovascular age-related macular degeneration has compl…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration [Phase 1]
Phase 1 trial evaluating the safety and tolerability of KH631 gene therapy in participants with neovascular age-related macular degeneration…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration [Phase 1]
Phase 1 trial update evaluating OLX10212 for neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema
This completed observational study assesses fluid resolution and the overall effectiveness of Beovu (brolucizumab) in patients with neovascu…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) [Phase 1, Phase 2]
Two-part Phase 1/2 trial evaluating intravitreal Eye103 for safety and efficacy in diabetic macular edema and neovascular age-related macula…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration [Phase 3]
Phase 3 trial evaluating the aflibercept FYB203 biosimilar versus Eylea in neovascular age-related macular degeneration, reporting efficacy …
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration [Phase 4]
This Phase 4 trial studied blood levels of aflibercept after high-dose injections in both eyes for diabetic macular edema or neovascular age…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration [Phase 2]
Phase 2 trial evaluating the efficacy and safety of KHK4951 in neovascular age-related macular degeneration; the study status is active but …
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration [Phase 3]
Phase 3 study results report on the long-term safety and tolerability of faricimab in neovascular age-related macular degeneration, with res…